Jan 08, 2026
Aclarion’s AI Back Pain Tech Sees 114% Surge In Demand, Stock Soars

Aclarion Inc. (NASDAQ:ACON), a commercial-stage healthcare technology company developing biomarker-driven augmented intelligence tools to diagnose chronic low back pain, provided a corporate update on Thursday detailing operating momentum, clinical progress, and financial strength as it enters 2026. Commercial Momentum and…